Literature DB >> 12592246

A comparison of four screening methods for cervical neoplasia in a developing country.

Hendrik S Cronjé1, Groesbeck P Parham, Bruno F Cooreman, Amanda de Beer, Peter Divall, Roosmarie H Bam.   

Abstract

OBJECTIVE: The purpose of this study was to compare the results of cytologic examination, cervicography, direct acetic acid test, and magnified acetic acid test (speculoscopy) with the results of histologic examination. STUDY
DESIGN: The study was a prospective, descriptive, and analytic study that included 1286 women in a primary health facility who were screened by cytologic examination, cervicography, direct acetic acid test, and magnified acetic acid test (speculoscopy). Histologic evidence was obtained on all patients by means of cervical punch biopsies. The biopsy specimens were taken from aceto-white areas or areas suspicious of cancer. In normal individuals, the specimens were taken from the external cervical os at the 12 or 6 o'clock position, whichever was most convenient. Positive cases were treated by colposcopy and large loop excision of the transformation zone. Testing for human immunodeficiency virus infection was not done.
RESULTS: Of the 1286 women who were screened, 1093 women (85%) were eligible for analysis. The mean age of the women was 38.6 years. Because histologic evidence was obtained on all women, direct sensitivities and specificities could be calculated for each screening method. The sensitivity, specificity, and positive predictive values for cytologic examination were 53%, 95%, and 47%, respectively; for cervicography were 49%, 88%, and 26%, respectively; for the direct acetic acid test were 79%, 49%, and 12%, respectively; and for speculoscopy were 77%, 45%, and 11%, respectively. Of the 876 patients who were eligible for colposcopy, only 468 women (56%) eventually returned for colposcopy.
CONCLUSION: Cytologic examination, cervicography, the direct acetic acid test, and speculoscopy are not suited for screening in developing countries because of the low sensitivity of the cytologic examination and the low specificity of the other tests. Two or more tests combined will increase the sensitivity, but the specificity remains low. Screening methods in developing countries remain an urgent problem.

Entities:  

Mesh:

Year:  2003        PMID: 12592246     DOI: 10.1067/mob.2003.153

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

Review 1.  Fluorescence Imaging for Cancer Screening and Surveillance.

Authors:  K E Tipirneni; E L Rosenthal; L S Moore; A D Haskins; N Udayakumar; A H Jani; W R Carroll; A B Morlandt; M Bogyo; J Rao; Jason M Warram
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

2.  eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.

Authors:  Groesbeck P Parham; Mulindi H Mwanahamuntu; Krista S Pfaendler; Vikrant V Sahasrabuddhe; Daniel Myung; Gracilia Mkumba; Sharon Kapambwe; Bianca Mwanza; Carla Chibwesha; Michael L Hicks; Jeffrey S A Stringer
Journal:  J Low Genit Tract Dis       Date:  2010-07       Impact factor: 1.925

3.  Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya.

Authors:  E Were; Z Nyaberi; N Buziba
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

4.  'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia.

Authors:  Heather L White; Chishimba Mulambia; Moses Sinkala; Mulindi H Mwanahamuntu; Groesbeck P Parham; Linda Moneyham; Diane M Grimley; Eric Chamot
Journal:  Soc Sci Med       Date:  2012-03-07       Impact factor: 4.634

5.  Integrating cervical cancer prevention initiatives with HIV care in resource-constrained settings: A formative study in Durban, South Africa.

Authors:  Katie A Ports; Firoza Haffejee; Maghboeba Mosavel; Anjali Rameshbabu
Journal:  Glob Public Health       Date:  2015-02-05

Review 6.  Optical imaging for cervical cancer detection: solutions for a continuing global problem.

Authors:  Nadhi Thekkek; Rebecca Richards-Kortum
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

7.  A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer.

Authors:  Mark C Pierce; YaoYao Guan; Mary Kate Quinn; Xun Zhang; Wen-Hua Zhang; You-Lin Qiao; Philip Castle; Rebecca Richards-Kortum
Journal:  Cancer Prev Res (Phila)       Date:  2012-08-27

8.  Performance characteristics of Pap test, VIA, VILI, HR-HPV testing, cervicography, and colposcopy in diagnosis of significant cervical pathology.

Authors:  Adhemar Longatto-Filho; Paulo Naud; Sophie Fm Derchain; Cecília Roteli-Martins; Sílvio Tatti; Luciano Serpa Hammes; Luis Otavio Sarian; Mojca Eržen; Margherita Branca; Jean Carlos de Matos; Renata Gontijo; Marina Y S Maeda; Temístocles Lima; Silvano Costa; Stina Syrjänen; Kari Syrjänen
Journal:  Virchows Arch       Date:  2012-05-05       Impact factor: 4.064

9.  Comparative study of visual inspection of the cervix using acetic acid (VIA) and Papanicolaou (Pap) smears for cervical cancer screening.

Authors:  So Albert; Oa Oguntayo; Moa Samaila
Journal:  Ecancermedicalscience       Date:  2012-07-23

10.  Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix.

Authors:  P Ghosh; G Gandhi; P K Kochhar; V Zutshi; S Batra
Journal:  Indian J Med Res       Date:  2012-08       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.